Moody Aldrich Partners LLC Lowers Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Moody Aldrich Partners LLC trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 19.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 45,897 shares of the company’s stock after selling 10,998 shares during the period. Moody Aldrich Partners LLC’s holdings in HealthEquity were worth $4,404,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Holocene Advisors LP purchased a new position in shares of HealthEquity during the third quarter valued at approximately $1,246,000. GSA Capital Partners LLP purchased a new stake in shares of HealthEquity in the third quarter worth $638,000. Natixis Advisors LLC lifted its position in shares of HealthEquity by 29.8% in the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock valued at $17,122,000 after acquiring an additional 48,009 shares in the last quarter. Vaughan Nelson Investment Management L.P. grew its holdings in HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after buying an additional 226,563 shares in the last quarter. Finally, Loomis Sayles & Co. L P grew its stake in HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock valued at $92,216,000 after acquiring an additional 24,665 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HQY shares. BTIG Research lifted their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Barrington Research raised their price target on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Bank of America lifted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Finally, Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Buying and Selling

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,289 shares of company stock worth $3,355,718 in the last ninety days. 2.20% of the stock is owned by insiders.

HealthEquity Trading Up 3.2 %

Shares of NASDAQ HQY opened at $107.71 on Wednesday. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $107.89. The business has a fifty day moving average price of $99.74 and a 200 day moving average price of $87.87. The stock has a market capitalization of $9.33 billion, a P/E ratio of 98.82, a price-to-earnings-growth ratio of 1.86 and a beta of 0.54. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the previous year, the business earned $0.40 EPS. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.